The Journal of Organic Chemistry
Article
1H), 7.32−7.25 (m, 1H), 4.14 (d, J = 7.8 Hz, 1H), 3.57 (d, J = 8.0
Hz, 1H), 2.52−2.08 (m, 3H), 2.29 (s, 3H), 1.93−1.69 (m, 1H) ppm.
(s, 1H), 7.70 (ddd, J = 8.9, 4.1, 2.7 Hz, 1H), 7.29 (t, J = 9.0 Hz, 1H),
7.20 (s, 1H), 4.29 (t, J = 6.1 Hz, 2H), 4.06−4.02 (m, 4H), 4.00 (d, J =
11.7 Hz, 1H), 3.91−3.86 (m, 1H), 3.74 (dd, J = 11.6, 2.6 Hz, 1H),
3.62 (td, J = 11.4, 2.7 Hz, 1H), 2.82−2.75 (m, 3H), 2.61 (td, J = 11.7,
3.2 Hz, 1H), 2.13 (p, J = 6.5 Hz, 2H) ppm. 13C NMR (126 MHz,
CD3OD): δ 157.1, 155.6, 152.5, 149.2, 146.4, 124.5, 122.6, 122.5,
116.1, 115.9, 115.4, 109.1, 105.9, 102.0, 67.7, 66.8, 66.7, 55.2, 52.5,
48.5, 25.8 ppm. HRMS (ESI) m/z: [M + H]+ calcd for
C23H23ClFN5O3 472.1546, found 472.1530. FT-IR (KBr) ν = 3380,
3075, 2926, 2856, 2164, 1625, 1578, 1499, 1426, 1213, 1144, 1117,
856 cm−1.
1
22c. Crude yield: 8%. H NMR (500 MHz, CDCl3): δ 8.60−8.44
(m, 2H), 7.76−7.58 (m, 1H), 7.32−7.25 (m, 1H), 3.62−3.60 (m,
1H), 3.59 (d, J = 17.3 Hz, 1H), 3.31 (d, J = 17.3 Hz, 1H), 3.21 (td, J
= 8.4, 3.0 Hz), 2.75 (q, J = 8.8 Hz), 2.05−2.08 (m, 2H), 2.08−1.91
(m, 2H) ppm.
2-((1-Cyanoethyl)(ethyl)amino)-N-(2,6-dimethylphenyl)-
acetamide (23a). Purification solvent: 1:1 EtOAc/hexane. Yield: 57.4
1
mg (82%). H NMR (500 MHz, CDCl3): δ 8.26 (bs, 1H), 7.04 (m,
3H), 3.84 (q, J = 7.2 Hz, 1H), 3.43 (d, J = 17.6 Hz, 1H), 3.21 (d, J =
17.6 Hz, 1H), 2.82 (dq, J = 12.8, 7.3 Hz, 1H), 2.77−2.68 (m, 1H),
2.15 (s, 6H), 1.51 (d, J = 7.2 Hz, 3H), 1.19 (t, J = 7.2 Hz, 3H) ppm.
13C NMR (126 MHz, CDCl3): δ 168.3, 135.0, 133.4, 128.4, 127.5,
117.9, 54.7, 49.9, 48.8, 18.6, 18.0, 13.4 ppm. HRMS (ESI) m/z: [M +
H]+ calcd for C15H21N3O 260.1657, found 260.1647. FT-IR (KBr) ν
= 3232, 2978, 2943, 2921, 2164, 1663, 1595, 1507, 1458, 1428, 1204,
1118, 1096, 782 cm−1.
(R)-2-((2-Hydroxy-2-(3-hydroxyphenyl)ethyl)amino)acetonitrile
1
(27a). Purification solvent: EtOAc. Yield: 13 mg (26%). H NMR
(500 MHz, CD3OD): δ 7.17 (t, J = 8.0 Hz, 1H), 6.87−6.84 (m, 2H),
6.71 (ddd, J = 8.1, 2.4, 1.0 Hz, 1H), 4.73 (dd, J = 8.9, 3.8 Hz, 1H),
3.76 (s, 2H), 2.70 (dd, J = 13.1, 8.9 Hz, 1H), 2.60 (dd, J = 13.1, 3.9
Hz, 1H) ppm. 13C NMR (126 MHz, CD3OD) δ 157.20, 144.51,
128.99, 116.86, 114.88, 114.06, 112.52, 70.94, 63.23, 44.63 ppm.
HRMS (ESI) m/z: [M + H]+ calcd for C10H12N2O2 193.0972, found
193.0967. FT-IR (KBr) ν = 3270, 3080, 2920, 2165, 1592, 1456,
1280, 1156, 1073, 842 cm−1.
2-(((1H-Indol-3-yl)methyl)(methyl)amino)acetonitrile (24a).
Compound 24a was obtained in a mixture with 24b; 24b was
1
purified by flash chromatography. Crude yield: 17%. H NMR (500
(6R,7S,10S)-7,8,9,10-Tetrahydro-6H-6,10-methano-azepino[4,5-
g]quinoxaline-7-carbonitrile (28a). The reaction was carried out on
a 200 mg scale (0.95 mmol), following the general procedure above.
Purification: Silica gel column chromatography, 5:95 MeOH/CHCl3.
MHz, CDCl3): δ 8.17 (s, 1H), 7.74 (d, J = 8.0 Hz, 1H), 7.38 (dt, J =
8.0, 1.1 Hz, 1H), 7.23 (ddd, J = 8.0, 7.0, 0.9 Hz, 1H), 7.18 (d, J = 2.5
Hz, 1H), 7.15 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 3.81 (s, 2H), 3.46 (s,
2H), 2.50 (s, 3H) ppm. The spectral data were in agreement with
literature data.26
1
Yield: 201 mg (90% isolated yield, single cis-diastereomer). H NMR
(400 MHz, DMSO-d6): δ 9.33 (s, 2H), 8.41 (s, 1H), 8.40 (s, 1H),
4.64 (d, 4.0 Hz, 1H), 4.09 (d, 4.0 Hz, 1H), 3.91 (s, 1H), 3.83 (d, 12
Hz, 1H), 3.43 (d, 12 Hz, 1H), 2.97 (s, 2H) ppm. 13C NMR (100
MHz, DMSO-d6): δ188.6, 186.1, 183.7, 183.5, 182.8, 161.5, 161.1,
159.6, 156.5, 88.3, 86.2, 82.4, 80.3, 78.7 ppm. HRMS (ESI) m/z: [M
+ H]+ calcd for C14H13N4 237.1100; Found 237.1080. FT-IR (KBr) ν
= 529, 536, 553, 563, 576, 603, 610, 636, 699, 725, 748, 773, 808, 856,
880, 902, 936, 965, 1007, 1028, 1054, 1069, 1103, 1134, 1164, 1186,
1205, 1253, 1288, 1327, 1359, 1455, 1470, 1477, 1559, 1669, 1987,
2110, 2217, 2822, 2963, 3348, 3648, 3903.
2-(1H-Indol-3-yl)acetonitrile (24b). Purification solvent: 1:3
EtOAc/hexane. Yield: 29.5 mg (56%). 1H NMR (500 MHz,
CD3OD): δ 7.48 (dt, J = 8.0, 0.9 Hz, 1H), 7.28 (dt, J = 8.2, 0.9
Hz, 1H), 7.14 (s, 1H), 7.06 (ddd, J = 8.2, 7.1, 1.1 Hz, 1H), 6.98 (ddd,
J = 8.0, 7.1, 1.0 Hz, 1H), 3.84 (d, J = 0.9 Hz, 2H) ppm. The spectral
data were in agreement with literature data.56
2-((3-(10,11-Dihydro-5H-dibenzo[b,f ]azepin-5-yl)propyl)-
(methyl)amino)acetonitrile (25a). Compound 25a was obtained in a
mixture with 25b and 25c; each of these compounds was purified by
flash chromatography. Purification solvent: 1:3 EtOAc/hexane. Yield:
18.3 mg (22%). 1H NMR (500 MHz, CDCl3): δ 7.08−6.98 (m, 6H),
6.85 (td, J = 7.40, 1.30 Hz, 2H), 3.71 (t, J = 6.80 Hz, 2H), 3.37 (s,
2H), 3.09 (s, 4H), 2.42 (dd, J = 9.44, 4.63 Hz, 2H), 2.21 (s, 3H), 1.65
(p, J = 7.00 Hz, 2H) ppm. 13C NMR (126 MHz, CDCl3): δ 148.2,
134.3, 129.9, 126.4, 122.6, 119.9, 114.6, 53.6, 48.2, 45.3, 42.0, 32.2,
25.9 ppm. HRMS (ESI) m/z: [M + H]+ calcd for C20H23N3 306.1965,
found 306.1951. FT-IR (KBr) ν = 3057, 3002, 2924, 2949, 2164,
1585, 1573, 1499, 1452, 1330, 1180, 851 cm−1.
2-(10, 11-Dihydro-5H-dibenzo[b, f ]azepin-5-yl)-4-
(dimethylamino)butanenitrile (25b). Compound 25b was obtained
in a mixture with 25a and 25c; each of these compounds was purified
by flash chromatography. Compound 25b is stable in CDCl3 solution
at 8 °C and below but decomposes in solution at room temperature
and higher temperature to 10,11-dihydro-5H-dibenzo[b,f ]azepine
(25c). Purification solvent: 1:3 EtOAc/hexane. Yield: 18.5 mg (23%).
1H NMR (500 MHz, CDCl3): δ 7.19−7.08 (m, 6H), 6.97 (td, J = 7.4,
Synthesis of 3-(2,6-Dimethylphenyl)-1-ethyl-2-methylimidazoli-
din-4-one (32) from Cyanated Lidocaine 23a. The procedure was
adapted from a literature procedure.58 Nitrile 23a (1 mmol) was
added to a reaction flask; then MeOH (3 mL), NaBH4 (2 mmol), and
cobalt chloride (5 mol %) were added. The reaction was stirred for 24
h. The solvent was removed under reduced pressure, and the crude
reaction was purified over a short pad of silica (elution with EtOAc).
The expected reduction product was not obtained; instead, the
1
decyanation product 32 was obtained, as characterized by H NMR
and comparison with the relevant literature; the spectral data were in
agreement with literature data.45 Purification solvent: EtOAc. Yield:
1
28 mg (62%). H NMR (500 MHz, CDCl3): δ 7.15−7.04 (m, 3H),
4.39 (qt, J = 5.7, 1.5 Hz, 1H), 3.71 (dd, J = 14.7, 1.2 Hz, 1H), 3.12
(dd, J = 14.6, 1.8 Hz 1H), 2.86 (dq, J = 11.7, 7.4 Hz, 1H), 2.40 (dq, J
= 11.7, 7.0 Hz, 1H), 2.20 (s, 3H), 2.15 (s, 3H), 1.12 (t, J = 7.2 Hz,
3H), 1.07 (d, J = 5.7 Hz, 3H) ppm.
1.3 Hz, 2H), 3.96−3.86 (m, 2H), 3.67 (t, J = 7.8 Hz, 1H), 3.19 (s,
4H), 2.29 (s, 6H), 2.07−1.98 (m, 2H) ppm. 13C NMR (126 MHz,
CDCl3): δ 147.87, 134.30, 130.05, 126.59, 123.03, 119.69, 116.56,
56.39, 46.50, 41.82, 32.10, 30.02. HRMS (ESI) m/z: [M + H]+ calcd
for C20H23N3 306.1965, found 306.1955.FT-IR (KBr) ν = 3055, 3004,
2923, 2949, 2165, 1583, 1500, 1450, 1330, 1181, 851 cm−1.
ASSOCIATED CONTENT
■
S
* Supporting Information
The Supporting Information is available free of charge on the
10,11-Dihydro-5H-dibenzo[b,f ]azepine (25c). Compound 25c
was obtained in a mixture with 25a and 25b; each of these
compounds was purified by flash chromatography. Purification
Reaction optimization details, synthetic procedures, and
characterization for new and known compounds (PDF)
1
solvent: 1:3 EtOAc/hexane. Yield: 26.5 mg (50%). H NMR (500
MHz, CDCl3): δ 7.00 (td, J = 6.82, 1.57 Hz, 2H), 6.97 (dd, J = 7.45,
1.24 Hz, 2H), 6.70 (td, J = 7.39, 1.14 Hz, 2H), 6.66 (dd, J = 7.94, 1.01
Hz, 2H), 5.91 (bs, 1H), 3.01 (s, 4H) ppm. The spectral data were in
agreement with literature data.57
4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazo-
lin-6-yl)oxy)propyl)morpholine-3-carbonitrile (26a). Purification
solvent: 1:7 MeOH/CHCl3. Yield: 62 mg (49%). 1H NMR (500
MHz, CD3OD): δ 8.47 (s, 1H), 8.02 (dd, J = 6.7, 2.6 Hz, 1H), 7.75
AUTHOR INFORMATION
■
Corresponding Authors
ORCID
J
J. Org. Chem. XXXX, XXX, XXX−XXX